Human Papillomavirus Genotype Distribution in Cervical Intraepithelial Neoplasia Grade 2/3 and Invasive Cervical Cancer in Japanese Women
Japanese Journal of Clinical Oncology · 01.10.2014 · 44 (10) · 910-917
DOI: 10.1093/jjco/hyu112 ↗Kurz gefasst
Fachartikel in der Zeitschrift Japanese Journal of Clinical Oncology, online erschienen am 24.08.2014. Verfasst von Yukari Azuma und 11 weiteren Autor:innen. Beteiligte Einrichtung: WHO HPV LabNet Regional Reference Laboratory, WHO Western Pacific Region, Pathogen Genomics Center, National Institute of Infectious Diseases, Tokyo. Die Arbeit wurde bisher 67-mal zitiert (Crossref) und nennt 25 Literaturangaben.
Abstract (Originalsprache)
OBJECTIVE: Human papillomavirus vaccines are being introduced worldwide and are expected to reduce the incidence of cervical cancer. Here we report a cross-sectional study using a validated human papillomavirus genotyping method to reveal the human papillomavirus prevalence and genotype distribution in Japanese women with cervical intraepithelial neoplasia Grade 2/3 and invasive cervical cancer. METHODS: Cervical exfoliated cells were collected from 647 patients with abnormal cervical histology (cervical intraepithelial neoplasia Grade 2, n = 164; cervical intraepithelial neoplasia Grade 3, n = 334; and invasive cervical cancer, n = 149), and subjected to the PGMY-PCR-based genotyping assay. The association between human papillomavirus infection and lesion severity was calculated using a prevalence ratio. RESULTS: Overall, the prevalence of human papillomavirus deoxyribonucleic acid was 96.3% in cervical intraepithelial neoplasia Grade 2, 98.8% in cervical intraepithelial neoplasia Grade 3 and 88.0% in invasive cervical cancer (97.8% in squamous cell carcinoma and 71.4% in adenocarcinoma). The three most prevalent types were as follows: human papillomavirus 16 (29.3%), human papillomavirus 52 (27.4%) and human papillomavirus 58 (22.0%) in cervical intraepithelial neoplasia Grade 2; human papillomavirus 16 (44.9%), human papillomavirus 52 (26.0%) and human papillomavirus 58 (17.4%) in cervical intraepithelial neoplasia Grade 3; and human papillomavirus 16 (47.7%), human papillomavirus 18 (23.5%) and human papillomavirus 52 (8.7%) in invasive cervical cancer. The prevalence ratio of human papillomavirus 16 was significantly higher in cervical intraepithelial neoplasia Grade 3 compared with cervical intraepithelial neoplasia Grade 2 (prevalence ratio, 1.62; 95% confidence interval, 1.26-2.13) and in squamous cell carcinoma compared with cervical intraepithelial neoplasia Grade 3 (prevalence ratio, 1.55; 95% confidence interval, 1.25-1.87). Multiple infections decreased from cervical intraepithelial neoplasia Grade 2/3 (38.4/29.6%) to invasive cervical cancer (14.1%), whereas co-infections with human papillomavirus 16/52/58 were found in cervical intraepithelial neoplasia Grade 2/3. CONCLUSIONS: The results of this study provide pre-vaccination era baseline data on human papillomavirus type distribution in Japanese women and serve as a reliable basis for monitoring the future impact of human papillomavirus vaccination in Japan.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- WHO HPV LabNet Regional Reference Laboratory, WHO Western Pacific Region, Pathogen Genomics Center, National Institute of Infectious Diseases, Tokyo.
- Department of Obstetrics and Gynecology, NTT Medical Center Tokyo, Tokyo.
- Department of Obstetrics and Gynecology, Graduate School of Medicine, The University of Tokyo, Tokyo.
- Department of Obstetrics and Gynecology, Keio University School of Medicine, Tokyo, Japan.
- WHO HPV LabNet Regional Reference Laboratory, WHO Western Pacific Region, Pathogen Genomics Center, National Institute of Infectious Diseases, Tokyo ikuki@nih.go.jp.
Zitieren
APA
Azuma, Y., Kusumoto-Matsuo, R., Takeuchi, F., Uenoyama, A., Kondo, K., Tsunoda, H., Nagasaka, K., Kawana, K., Morisada, T., Iwata, T., Aoki, D., & Kukimoto, I. (2014). Human Papillomavirus Genotype Distribution in Cervical Intraepithelial Neoplasia Grade 2/3 and Invasive Cervical Cancer in Japanese Women. Japanese Journal of Clinical Oncology, 44(10), 910-917. https://doi.org/10.1093/jjco/hyu112
Vancouver
Azuma Y, Kusumoto-Matsuo R, Takeuchi F, Uenoyama A, Kondo K, Tsunoda H, et al. Human Papillomavirus Genotype Distribution in Cervical Intraepithelial Neoplasia Grade 2/3 and Invasive Cervical Cancer in Japanese Women. Japanese Journal of Clinical Oncology. 2014;44(10):910-917. doi:10.1093/jjco/hyu112
BibTeX
@article{Azuma2014,
author = {Azuma, Yukari and Kusumoto-Matsuo, Rika and Takeuchi, Fumihiko and Uenoyama, Asami and Kondo, Kazunari and Tsunoda, Hajime and Nagasaka, Kazunori and Kawana, Kei and Morisada, Tohru and Iwata, Takashi and Aoki, Daisuke and Kukimoto, Iwao},
title = {Human Papillomavirus Genotype Distribution in Cervical Intraepithelial Neoplasia Grade 2/3 and Invasive Cervical Cancer in Japanese Women},
journal = {Japanese Journal of Clinical Oncology},
year = {2014},
volume = {44},
number = {10},
pages = {910--917},
doi = {10.1093/jjco/hyu112}
}
EUVIMED